Yes, diabetes is a chronic disease. The CDC classifies it as a “long-lasting condition” with a lifetime case definition, meaning once diagnosed, it requires ongoing management for the rest of a person’s life. This applies to both type 1 and type 2 diabetes, though the two forms differ in cause, onset, and treatment. Understanding what “chronic” actually means in practice helps explain why diabetes demands so much daily attention and why it carries such serious long-term risks when poorly controlled.
What Makes Diabetes “Chronic”
A chronic disease is one that lasts a year or more and requires ongoing medical attention, limits daily activities, or both. Diabetes fits every part of that definition. It doesn’t resolve on its own, it can’t be cured with a course of treatment, and it requires daily self-management alongside regular medical checkups for the rest of your life.
Type 1 diabetes occurs when the immune system destroys the cells in the pancreas that produce insulin. This process is irreversible, so people with type 1 need external insulin from the day of diagnosis onward. Type 2 diabetes develops when the body becomes resistant to insulin or stops producing enough of it. While type 2 can sometimes be put into remission (more on that below), the underlying tendency toward high blood sugar never fully disappears.
One exception worth noting: gestational diabetes, which develops during pregnancy, usually resolves after delivery. However, women who experience it face a 50% higher risk of developing type 2 diabetes later in life, often within five years. And some women diagnosed during pregnancy actually had undiagnosed diabetes beforehand, in which case it is a lifelong condition.
How Diabetes Is Diagnosed
Diabetes is diagnosed when blood sugar consistently exceeds specific thresholds. The most common tests and their diagnostic cutoffs are:
- A1C test: 6.5% or higher (normal is below 5.7%; prediabetes falls between 5.7% and 6.4%)
- Fasting blood glucose: 126 mg/dL or higher (normal is below 100 mg/dL; prediabetes is 100 to 125 mg/dL)
- Oral glucose tolerance test: 200 mg/dL or higher two hours after drinking a glucose solution
- Random blood glucose: 200 mg/dL or higher, taken at any time regardless of meals
The A1C test is particularly useful because it reflects average blood sugar over the previous two to three months rather than a single snapshot. Prediabetes, the stage before full diabetes, is itself a warning sign that the chronic process is already underway.
What Daily Management Looks Like
Living with diabetes means building medical management into your everyday routine. This is the part of “chronic disease” that people feel most directly. The CDC recommends a care schedule that touches nearly every part of daily life and extends across the entire year.
Every day, you’re expected to check your blood sugar (sometimes multiple times), take any prescribed medications, get at least 30 minutes of moderate physical activity, eat in a way that keeps blood sugar within your target range, and inspect your feet for cuts, sores, or other changes that could signal nerve or circulation problems. That last one surprises many people, but foot complications are one of the most common and preventable consequences of diabetes.
Beyond daily tasks, there’s a rolling schedule of medical appointments. Every three to six months, you need an A1C test and a doctor visit to review your blood pressure, weight, and overall care plan. The frequency depends on how well your blood sugar is controlled. Once a year, you need kidney function tests, a cholesterol check, a dilated eye exam, a complete foot exam, a hearing check, a dental exam, and a flu shot. This level of ongoing surveillance is the hallmark of a chronic condition.
Long-Term Complications
The reason diabetes demands such vigilant management is that sustained high blood sugar damages blood vessels throughout the body. These complications fall into two broad categories based on the size of the blood vessels affected.
Small-vessel damage (microvascular complications) leads to three major problems. Retinopathy affects the eyes and can progress to vision loss. Neuropathy damages nerves, particularly in the feet and legs, causing pain, numbness, and in severe cases foot ulcers, gangrene, or amputation. Nephropathy affects the kidneys, starting with protein leaking into the urine and potentially progressing to kidney failure.
Large-vessel damage (macrovascular complications) increases the risk of heart attack, stroke, and peripheral artery disease. Cardiovascular disease is the leading cause of death among people with diabetes. In 2021, diabetes directly caused 1.6 million deaths worldwide, and 47% of those deaths occurred in people under age 70. An additional 530,000 kidney disease deaths were attributed to diabetes, and high blood sugar contributes to roughly 11% of all cardiovascular deaths globally.
The critical takeaway is that these complications are largely preventable. Keeping blood sugar, blood pressure, and cholesterol under control, combined with regular screening, dramatically reduces the risk of every one of these outcomes.
Can Type 2 Diabetes Go Into Remission?
Type 2 diabetes has traditionally been treated as irreversible, with management focused on medication and blood sugar control rather than reversal. That view is shifting. A consensus statement now defines remission as maintaining an A1C below 6.5% for at least three months while off all glucose-lowering medications.
Remission is achievable for some people, typically through significant weight loss, dietary changes, or metabolic surgery. But remission is not the same as a cure. The word “remission” was chosen deliberately, because the underlying metabolic dysfunction can return. People in remission still need regular monitoring, and many eventually see their blood sugar rise again over time. This is why diabetes remains classified as chronic even when someone’s numbers temporarily normalize.
The Scale of Diabetes as a Chronic Condition
The global burden of diabetes has grown dramatically. The number of people living with the disease rose from 200 million in 1990 to 830 million in 2022. Among adults 18 and older, prevalence doubled from 7% to 14% over that same period. This makes diabetes one of the fastest-growing chronic diseases in the world.
The economic impact reflects just how resource-intensive a chronic disease can be. In the United States alone, the total estimated cost of diagnosed diabetes in 2022 was $412.9 billion. Of that, $306.6 billion went to direct medical costs: doctor visits, medications, hospital stays, and ongoing monitoring. The remaining $106.3 billion came from indirect costs, including $35.8 billion in reduced productivity while at work, $28.3 billion in disability-related unemployment, and $32.4 billion in lost productivity from over 338,000 premature deaths. These numbers illustrate why public health systems worldwide treat diabetes not just as an individual medical problem but as a systemic economic challenge.